Wells Fargo & Company Journey Medical Corp Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DERM
# of Institutions
37Shares Held
3.11MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$5.65 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA310KShares$2.03 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.295KShares$1.93 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny264KShares$1.72 Million0.0% of portfolio
-
American Financial Group Inc180KShares$1.18 Million0.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $75.7M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...